Methotrexate and subcutaneous administration.JAAD.1992; 26: 1008.
2.
Psoriasis Forum. February 1995; 1: 3.
3.
Methotrexate and NSAIDs.J Rheumatol.1993; 20: 1297–1302.
4.
Methotrexate and NSAIDs.Br J Clin Pharmac.1994; 37: 453–456.
5.
Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis.JAAD.1993; 23(3): 466–469.
6.
Monitoring methotrexate for hepatotoxicity.JAAD.1994; 31: 969–977.
7.
Methotrexate for rheumatoid arthritis.Arthritis and Rheumatism.1994; 37: 316–328.
8.
Lederle warning of association with lymphoma, revised packet insert.
9.
PUVA and methotrexate therapy of psoriasis.Br J Dermatol.1994; 131: 220–225.
10.
Complications of immunosuppression associated with weekly low dose methotrexate.J Rheumatol.1991; 18: 1172–1175.
11.
Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis.N Engl J Med.1993; 328: 1317–1321.
